A filing by the Department of Justice has asked Judge Matthew Kacsmaryk, a Trump appointee who opposes abortion, to block the ...

Digital therapeutics (DTx) developer Hinge Health has published a new prospectus for an initial public offering (IPO) in the ...

Financial terms of the new agreement include an upfront payment to secure rights to Alchemab's lead ALS candidate, ATLX-1282, ...

The 'Choose Europe for Science' scheme was revealed by President of the European Commission Ursula Von Der Leyen during a ...

The phase 2 PIVOT-HD trial of Novartis-partnered PTC518 (votoplam) showed that the oral mRNA splicing modifier was able to ...

Novo Nordisk has pulled ahead in the race to bring the first oral GLP-1 for obesity to market. The company announced Friday ...

Meanwhile, there was more encouraging news for the UK's science base after it emerged that the country's research teams have ...

That is according to the chief executive of the American Association for the Advancement of Science (AAAS), Sudip Parikh, who ...

PT: How does pharma deal with diverse geographies during launch? AH: This is difficult! Local and national reimbursement environments vary significantly by country and many will reference ...

Pharmaceutical companies approach a significant wave of patent expirations by 2030. This includes exclusivity rights set to expire for 569 medications valued at $278 billion, based on 2022 sales.

An artificial intelligence-powered tool for triaging patients with suspicious skin lesions, developed by Skin Analytics, will be used by the NHS to reduce waiting times. DERM (Deep Ensemble for ...

The US federal government intends to spend $500 million on a project to develop universal vaccines that can protect against multiple virus variants at the same time. That's the conclusion of an ...